Neglected Tropical Diseases Diagnosis is the procedure to test if the patient have the Neglected Tropical.
The global Neglected Tropical Diseases Diagnosis market was valued at US$ 6267.3 million in 2023 and is anticipated to reach US$ 8008.3 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Diseases Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Diseases Diagnosis.
Report Scope
The Neglected Tropical Diseases Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neglected Tropical Diseases Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Diseases Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Beckman Coulter/Danaher
Bio-Rad Laboratories, Inc.
Life Technology
Novartis Diagnostics., Ltd.
Ortho-Clinical Diagnostics
Premier Medical Corporation Ltd.
Siemens Healthcare
Wako Chemicals, Inc.
Segment by Type
Conventional Method
Molecular/Modern Method
Segment by Application
Clinical Labs
Hospitals /Clinics
Home Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neglected Tropical Diseases Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Diseases Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Conventional Method
1.2.3 Molecular/Modern Method
1.3 Market by Application
1.3.1 Global Neglected Tropical Diseases Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Labs
1.3.3 Hospitals /Clinics
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Diseases Diagnosis Market Perspective (2019-2030)
2.2 Neglected Tropical Diseases Diagnosis Growth Trends by Region
2.2.1 Global Neglected Tropical Diseases Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neglected Tropical Diseases Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 Neglected Tropical Diseases Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 Neglected Tropical Diseases Diagnosis Market Dynamics
2.3.1 Neglected Tropical Diseases Diagnosis Industry Trends
2.3.2 Neglected Tropical Diseases Diagnosis Market Drivers
2.3.3 Neglected Tropical Diseases Diagnosis Market Challenges
2.3.4 Neglected Tropical Diseases Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Diseases Diagnosis Players by Revenue
3.1.1 Global Top Neglected Tropical Diseases Diagnosis Players by Revenue (2019-2024)
3.1.2 Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Neglected Tropical Diseases Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neglected Tropical Diseases Diagnosis Revenue
3.4 Global Neglected Tropical Diseases Diagnosis Market Concentration Ratio
3.4.1 Global Neglected Tropical Diseases Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Diagnosis Revenue in 2023
3.5 Neglected Tropical Diseases Diagnosis Key Players Head office and Area Served
3.6 Key Players Neglected Tropical Diseases Diagnosis Product Solution and Service
3.7 Date of Enter into Neglected Tropical Diseases Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Diseases Diagnosis Breakdown Data by Type
4.1 Global Neglected Tropical Diseases Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global Neglected Tropical Diseases Diagnosis Forecasted Market Size by Type (2025-2030)
5 Neglected Tropical Diseases Diagnosis Breakdown Data by Application
5.1 Global Neglected Tropical Diseases Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global Neglected Tropical Diseases Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neglected Tropical Diseases Diagnosis Market Size (2019-2030)
6.2 North America Neglected Tropical Diseases Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024)
6.4 North America Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neglected Tropical Diseases Diagnosis Market Size (2019-2030)
7.2 Europe Neglected Tropical Diseases Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024)
7.4 Europe Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neglected Tropical Diseases Diagnosis Market Size (2019-2030)
9.2 Latin America Neglected Tropical Diseases Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024)
9.4 Latin America Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa Neglected Tropical Diseases Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Neglected Tropical Diseases Diagnosis Introduction
11.1.4 Abbott Laboratories Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter/Danaher
11.2.1 Beckman Coulter/Danaher Company Detail
11.2.2 Beckman Coulter/Danaher Business Overview
11.2.3 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Introduction
11.2.4 Beckman Coulter/Danaher Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.2.5 Beckman Coulter/Danaher Recent Development
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Bio-Rad Laboratories, Inc. Company Detail
11.3.2 Bio-Rad Laboratories, Inc. Business Overview
11.3.3 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Introduction
11.3.4 Bio-Rad Laboratories, Inc. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.3.5 Bio-Rad Laboratories, Inc. Recent Development
11.4 Life Technology
11.4.1 Life Technology Company Detail
11.4.2 Life Technology Business Overview
11.4.3 Life Technology Neglected Tropical Diseases Diagnosis Introduction
11.4.4 Life Technology Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.4.5 Life Technology Recent Development
11.5 Novartis Diagnostics., Ltd.
11.5.1 Novartis Diagnostics., Ltd. Company Detail
11.5.2 Novartis Diagnostics., Ltd. Business Overview
11.5.3 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Introduction
11.5.4 Novartis Diagnostics., Ltd. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.5.5 Novartis Diagnostics., Ltd. Recent Development
11.6 Ortho-Clinical Diagnostics
11.6.1 Ortho-Clinical Diagnostics Company Detail
11.6.2 Ortho-Clinical Diagnostics Business Overview
11.6.3 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Introduction
11.6.4 Ortho-Clinical Diagnostics Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.6.5 Ortho-Clinical Diagnostics Recent Development
11.7 Premier Medical Corporation Ltd.
11.7.1 Premier Medical Corporation Ltd. Company Detail
11.7.2 Premier Medical Corporation Ltd. Business Overview
11.7.3 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Introduction
11.7.4 Premier Medical Corporation Ltd. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.7.5 Premier Medical Corporation Ltd. Recent Development
11.8 Siemens Healthcare
11.8.1 Siemens Healthcare Company Detail
11.8.2 Siemens Healthcare Business Overview
11.8.3 Siemens Healthcare Neglected Tropical Diseases Diagnosis Introduction
11.8.4 Siemens Healthcare Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.8.5 Siemens Healthcare Recent Development
11.9 Wako Chemicals, Inc.
11.9.1 Wako Chemicals, Inc. Company Detail
11.9.2 Wako Chemicals, Inc. Business Overview
11.9.3 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Introduction
11.9.4 Wako Chemicals, Inc. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.9.5 Wako Chemicals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
Beckman Coulter/Danaher
Bio-Rad Laboratories, Inc.
Life Technology
Novartis Diagnostics., Ltd.
Ortho-Clinical Diagnostics
Premier Medical Corporation Ltd.
Siemens Healthcare
Wako Chemicals, Inc.
*If Applicable.